The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Zein & Samar Obagi Family Trust since 2006.
The trader's CIK number is 1382982.
At the time of the last reporting, Zein & Samar Obagi Family Trust was the 10% Owner of Obagi Medical Products, Inc.. (stock ticker symbol OMPI).
Also see all insider trading activities at Obagi Medical Products, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | OMPI | 0 | $0 | 1,900,400 | $36,410,902 | 0 | $0 |
| 2006 | OMPI | 0 | $0 | 405,000 | $4,143,150 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-10-17 | OMPI | Sale | 1,300,000 | 20.00 | 26,000,000 |
| 2007-10-10 | OMPI | Sale | 14,345 | 20.57 | 295,076 |
| 2007-10-11 | OMPI | Sale | 3,607 | 21.10 | 76,093 |
| 2007-10-10 | OMPI | Sale | 5,948 | 20.94 | 124,545 |
| 2007-10-11 | OMPI | Sale | 1,100 | 20.79 | 22,866 |
| 2007-09-20 | OMPI | Sale | 681 | 17.72 | 12,064 |
| 2007-09-20 | OMPI | Sale | 24,319 | 17.40 | 423,223 |
| 2007-09-14 | OMPI | Sale | 50,400 | 17.07 | 860,580 |
| 2007-09-11 | OMPI | Sale | 800 | 17.86 | 14,284 |
| 2007-09-11 | OMPI | Sale | 8,600 | 17.61 | 151,428 |
| 2007-09-10 | OMPI | Sale | 25,286 | 17.50 | 442,580 |
| 2007-09-10 | OMPI | Sale | 25,235 | 17.18 | 433,411 |
| 2007-09-10 | OMPI | Sale | 75,179 | 17.11 | 1,286,237 |
| 2007-09-07 | OMPI | Sale | 317,300 | 17.18 | 5,452,165 |
| 2007-08-13 | OMPI | Sale | 2,600 | 17.14 | 44,551 |
| 2007-08-10 | OMPI | Sale | 20,000 | 17.00 | 340,000 |
| 2007-07-20 | OMPI | Sale | 25,000 | 17.27 | 431,799 |
| 2006-12-14 | OMPI | Sale | 405,000 | 10.23 | 4,143,150 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zein & Samar Obagi Family Trust (10% Owner of Obagi Medical Products, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.